Literature DB >> 8387920

N-isopropyl-p-iodoamphetamine receptors in normal and cancerous tissue of the human lung.

E Tanaka1, M Mishima, K Kawakami, N Sakai, N Sugiura, T Taniguchi, K Kuno.   

Abstract

N-Isopropyl-p-iodoamphetamine (IMP) receptors in normal human lung tissue were characterized using a radioligand binding assay with iodine-125 IMP as the ligand. Saturation binding studies revealed the presence of two binding sites with dissociation constant (Kd) values of 53 +/- 2 and 4687 +/- 124 nM and maximum binding capacity (Bmax) values of 7 +/- 1 and 133 +/- 27 pmol/mg protein (n = 5) respectively. The IC50 values of various amines were as follows: IMP, 9 x 10(-5) M; propranolol, 5 x 10(-4) M; haloperidol, 6 x 10(-4) M; ketamine, 9 x 10(-3) M; dopamine, 1 x 10(-2) M. The IMP receptors of cancerous tissue obtained from human lung also had two binding sites with Kd values of 54 +/- 2 and 5277 +/- 652 nM and Bmax values of 7 +/- 1 and 103 +/- 21 pmol/mg protein (n = 3) respectively. There was no significant difference in binding parameters between normal and cancerous lung tissue. These results demonstrate the existence of IMP receptors and suggest that cancer does not affect the nature of IMP receptors in human lung tissue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387920     DOI: 10.1007/bf00169803

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  20 in total

1.  Nicotinic acetylcholine receptors in the rat stomach: I. (-)-[3H]nicotine binding.

Authors:  H Nishikawa; T Taniguchi; H Ninomiya; M Fujiwara
Journal:  Eur J Pharmacol       Date:  1988-01-27       Impact factor: 4.432

2.  Radiopharmaceuticals. XIX. 11C-labeled octylamine, a potential diagnostic agent for lung structure and function.

Authors:  J S Fowler; B M Gallagher; R R MacGregor; A P Wolf; A N Ansari; H L Atkins; D N Slatkin
Journal:  J Nucl Med       Date:  1976-08       Impact factor: 10.057

3.  gamma-Aminobutyric acid receptor binding in mammalian brain. Heterogeneity of binding sites.

Authors:  R W Olsen; M O Bergman; P C Van Ness; S C Lummis; A E Watkins; C Napias; D V Greenlee
Journal:  Mol Pharmacol       Date:  1981-03       Impact factor: 4.436

4.  A noninvasive procedure for in vivo assay of a lung amine endothelial receptor.

Authors:  J J Touya; J Rahimian; D E Grubbs; H F Corbus; L R Bennett
Journal:  J Nucl Med       Date:  1985-11       Impact factor: 10.057

5.  Effect of antidepressant and narcoleptic drugs on N-isopropyl p-iodoamphetamine biodistribution in animals.

Authors:  J L Moretti; B L Holman; L Delmon; A Carmel; D Johnson; P Moingeon; M Blau
Journal:  J Nucl Med       Date:  1987-03       Impact factor: 10.057

6.  Measurement of metabolic extraction of tracers in the lung using a multiple indicator dilution technique.

Authors:  J Rahimian; E C Glass; J J Touya; S F Akber; L S Graham; L R Bennett
Journal:  J Nucl Med       Date:  1984-01       Impact factor: 10.057

7.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

8.  Interactions of phenylalkylamines with human lung membrane and microsome preparation.

Authors:  J L Moretti; R Zini; D Morin; Y Joulin; G Desplanches; N Caillat-Vigneron; J P Tillement
Journal:  Nucl Med Commun       Date:  1987-02       Impact factor: 1.690

9.  Fate of isopropyl-iodoamphetamine (IMP) in rat liver microsomes.

Authors:  Y Joulin; J L Moretti; H Hoellinger; G Defer
Journal:  Nucl Med Commun       Date:  1992-02       Impact factor: 1.690

10.  First pass uptake of 14C-propranolol by the lung.

Authors:  D M Geddes; K Nesbitt; T Traill; J P Blackburn
Journal:  Thorax       Date:  1979-12       Impact factor: 9.139

View more
  1 in total

1.  New design of N-isopropyl-p-[123I]iodoamphetamine (123I-IMP) lung imaging in the patient with lung cancer.

Authors:  E Tanaka; M Mishima; K Kawakami; N Sakai; N Sugiura; T Taniguchi; M Ohi; H Itoh; K Kuno
Journal:  Ann Nucl Med       Date:  1995-11       Impact factor: 2.668

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.